Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 221 results found. Search for [ COVID-19 vaccine candidates from India ]

Results 1 to 21 of 221
Joe C Mathew
December 2, 2020
Of the 8,936 respondents, 59 percent say they will not rush to vaccinate themselves against the pandemic even if it is made available by February 2021


PB Jayakumar
December 1, 2020
Ministry of Health and Family Welfare is in discussion with three suppliers to place orders for syringes or is seeking to prepone deliveries of already placed orders with them


PTI
November 30, 2020
Citing data from across states, India Ratings and Research said state governments need to galvanise the local bureaucracy and leverage both the soft and hard infrastructure, along with the healthcare spends, for favourable outcomes on this front


Mohammad Haaris Beg
November 30, 2020
The coronavirus is known to cause respiratory infection in patients who are affected by it. Air Hunger is a symptom of the damage done to the lungs by the infection brought on by COVID-19


Associated Press
November 30, 2020
Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the US and Europe. US hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day


BusinessToday.In
November 30, 2020
There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute


BusinessToday.In
November 29, 2020
India to develop vaccines for 60 percent of developing nations; 24 manufacturing units among 19 firms to develop vaccine in India: Bhargava


BusinessToday.In
November 27, 2020
After the publication of early data from phase-3 clinical trials, drugmakers Pfizer and BioNTech have sought regulatory approval to deploy their inoculation under emergency-use rules. American biotech company Moderna is also likely to do the same soon


BusinessToday.In
November 27, 2020
Serum Institute of India is expected to produce 100 crore doses of the Oxford-AstraZeneca vaccine candidate. These doses will be given to middle and low-income countries, including India. SII has now agreed to provide 3 crore doses to Bangladesh


PTI
November 27, 2020
The mission envisages Covid-19 vaccine development with end-to-end focus from preclinical through clinical development and manufacturing and regulatory facilitation, the DBT said


BusinessToday.In
November 26, 2020
SII has partnered with AstraZeneca and Oxford University for the manufacturing and distribution of its COVID-19 vaccine candidate 'Covishield' in India and other countries


Rajeev Dubey
New Delhi, November 25, 2020
In stark contrast to the mayhem around the world, India's top three candidates - Serum-Oxford, Bharat Biotech and Zydus Cadila continued their scientific pursuits unobtrusively (the fourth, DRL-Gamaleya, just started India trials). At least 16 more vaccines are under development at home


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


Joe C Mathew
November 24, 2020
In an open letter to Prime Minister Narendra Modi on November 24, the civil society representatives said the current incidence, prevalence, and fatality status of COVID-19 disease in India, do not call for such an approach


BusinessToday.In
November 24, 2020
Vardhan says it makes no sense to consider Pfizer as pharma major is yet to get approval in the US. After requisite approvals, US pharma major will have to cater to needs of its own country's population first


BusinessToday.In
November 23, 2020
Centre is worried about the caseload surge in urban centres, which has resulted in the enforcement of measures such as curfews by state governments.


BusinessToday.In
November 23, 2020
Earlier on Monday, the Oxford-AstraZeneca team announced that one of the dosing regimens of the vaccine might be 90% effective in preventing COVID-19 infection


BusinessToday.In
November 23, 2020
India will get a vaccine in the first three months of 2021; 30 of the total 250 global vaccine candidates are looking to manufacture in India, out of which five are already in the clinical trial phase: Dr. Harsh Vardhan


BusinessToday.In
November 23, 2020
Vaccine can be easily manufactured, transported and stored at domestic fridge temperature (2-8 degrees C). This means it can be easily distributed using existing medical facilities such as doctor's surgeries and local pharmacies, allowing for the vaccine to be deployed very rapidly, said Oxford University


PAGES 1 OF 12  12345